Kinetics of antibody response to Haemophilus influenzae type b vaccines

Current Medical Research and Opinion

Volumn 15, Issue 2, 1999, Pages 105-112

  Madore, Dace Viceps ^a   Johnson Kraines, C L ^c   Rothstein, E P ^b   Smith, D H ^d  

^a PFIZER INC   (United States)

^b Levinson Institute ^*  (United States)

^c Levinson Institute   (United States)

^d David H Smith Foundation   (United States)

Author keywords

Antibody kinetics; Haemophilus influenza type b; Vaccines

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNIZATION; INFANT; NORMAL HUMAN; PRESCHOOL CHILD;

EID: 0032980241     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999909113370     Document Type: Article

References (26)

1. Anderson, P. (1978). Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J. Immunol., 120(3), 866-870.
2. Anderson, P. (1984). The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b [letter]. J. Infect. Dis., 149(6), 1034-1035.
3. Anderson, P., Peter, G., Johnston, R. B. J., Wetterlow, L. H. and Smith, D. H. (1972). Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J. Clin. Invest., 51(1), 39-44.
4. Anderson, P., Smith, D. H., Ingram, D. L., Wilkins, J., Wehrle, P. F. and Howie, V. M. (1977). Antibody of polyribophosphate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate. J. Infect. Dis., 136, S57-S62.
5. Anderson, P. W. and Eby, R. J. Filed May 5, 1986; issued February 20, 1990. United States patent 4, 902, 506.
6. Einhorn, M. S., Granoff, D. M., Nahm, M. H., Quinn, A. and Shackelford, P. G. (1987). Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J. Pediatr., 111(5), 783-788.
7. Fothergill, L. D. and Wright, J. (1933). Influenzal meningitis - the relation of age incidence to the bactericidal power of blood against the causal organism. J. Immunol., 24, 273-284.
8. Granoff, D. M. and Nankervis, G. A. (1976). Cellulitis due to Haemophilus influenzae type b. Antigenemia and antibody responses. Am. J. Dis. Child, 130(11), 1211-1214.
9. Kayhty, H., Peltola, H., Karanko, V. and Makela, P. H. (1983). The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis., 147(6), 1100.
10. La Scolea Jr. L. J., Rosales, S. V. and Ogra, P. L. (1985). Haemophilus influenzae type b infection in childhood: History of bacteremia and antigenemia. Infect. Immun., 50(3), 753-756.
11. Madore, D. V. (1996). Impact of immunization on Haemophilus influenzae type b disease. Infect. Agents Dis., 5(1), 8-20.
12. 197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics, 86(4), 527-534.
13. 197 conjugate vaccine in 1- to 6-month-old infants. Pediatrics, 85(3), 331-337.
14. O'Reilly, R. J., Anderson, P., Ingram, D. L., Peter, G. and Smith, D. H. (1975). Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J. Clin. Invest., 56(4), 1012-1022.
15. Peltola, H., Kayhty, H., Sivonen, A. and Makela, H. (1977). Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccines 3 months to 5 years of age in Finland. Pediatrics, 60(5), 730-737.
16. Phipps, D. C., West, J., Eby, R., Koster, M., Madore, D. V. and Quataert, S. A. (1990). An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J. Immunol. Methods, 135(1-2), 121-128.
17. Pillai, S., Ciciriello, S., Koster, M. and Eby, R. (1991). Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b. Infect. Immun., 59(12), 4371-4376.
18. Pillai, S., Millane, S. A., Eby, R. and Smith, D. H. (1989). A comparison of Haemophilus influenzae type b (Hib) polysaccharide and conjugate vaccines for their capacity to absorb anti-PRP antibodies. Pediatr. Res., 25(4), 187A.
19. Robbins, J. B., Parke, J. C. J., Schneerson, R. and Whisnant, J. K. (1973). Quantitative measurement of 'natural' and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr. Res., 7(3), 103-110.
20. 197 conjugate and polysaccharide vaccines. Am. J. Dis. Child, 145(8), 898-900.
21. Santosham, M., Reid, R., Letson, G. W., Wolff, M. C. and Siber, G. (1990). Passive immunization for infection with Haemophilus influenzae type b. Pediatrics, 85(4), 662-666.
22. Seid, R. C., Boykins, R. A., Liu, D. F., Kimbrough, K. W., Hsieh, C. L. and Eby, R. (1989). Chemical evidence for covalent linkages of a semi-synthetic glycoconjugate vaccine for Haemophilus influenzae type b disease. Glycoconj. J., 6, 489-498.
23. Shapiro, E. D. and Ward, J. I. (1991). The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol. Rev., 13, 113-142.
24. Singleton, R. J., Davidson, N. M., Desmet, I. J., Berner, J. E., Wainwright, R. B., Bulkow, L. R., Lilly, C. M. and Siber, G. R. (1994). Decline of Haemophilus influenzae type b disease in a region of high risk: Impact of passive and active immunization. Pediatr. Infect. Dis. J., 13(5), 362-367.
25. Smith, D. H., Hann, S., Howie, V. M., Ploussard, J. H., Harding, A. L. and Anderson, P. (1973). Studies on the prevalence of antibodies to Haemophilus influenzae type b. In: Sell, S. H. W. and Karzon, D. T. (Eds), Haemophilus influenzae. Vanderbilt University Press, Nashville, pp. 175-185.
26. Wenger, J. D. (1994). Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis. Infect. Agents Dis., 2, 324-332.